Counterpoint Quantitative Equity ETF $CPAI Shares Bought by Intrua Financial LLC

Intrua Financial LLC boosted its position in shares of Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report) by 24.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 50,275 shares of the company’s stock after acquiring an additional 9,734 shares during the period. Intrua Financial LLC owned 0.51% of Counterpoint Quantitative Equity ETF worth $2,599,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CPAI. Counterpoint Mutual Funds LLC boosted its position in shares of Counterpoint Quantitative Equity ETF by 5.3% in the first quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock worth $64,758,000 after purchasing an additional 78,500 shares during the period. Nilsine Partners LLC raised its position in shares of Counterpoint Quantitative Equity ETF by 3.6% during the 2nd quarter. Nilsine Partners LLC now owns 229,706 shares of the company’s stock valued at $11,936,000 after purchasing an additional 8,084 shares during the period. NewEdge Advisors LLC raised its position in shares of Counterpoint Quantitative Equity ETF by 230.6% during the 2nd quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock valued at $5,782,000 after purchasing an additional 77,610 shares during the period. Concurrent Investment Advisors LLC raised its position in shares of Counterpoint Quantitative Equity ETF by 8.2% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 100,854 shares of the company’s stock valued at $5,240,000 after purchasing an additional 7,641 shares during the period. Finally, Cetera Investment Advisers lifted its stake in shares of Counterpoint Quantitative Equity ETF by 65.1% during the 1st quarter. Cetera Investment Advisers now owns 107,891 shares of the company’s stock valued at $4,509,000 after buying an additional 42,559 shares in the last quarter.

Counterpoint Quantitative Equity ETF Stock Performance

CPAI opened at $52.58 on Friday. The stock has a market cap of $530.01 million, a price-to-earnings ratio of -63,045.56 and a beta of 1.18. The firm’s fifty day moving average is $52.43 and its 200 day moving average is $48.37. Counterpoint Quantitative Equity ETF has a fifty-two week low of $37.29 and a fifty-two week high of $53.96.

Counterpoint Quantitative Equity ETF Profile

(Free Report)

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.

Featured Stories

Institutional Ownership by Quarter for Counterpoint Quantitative Equity ETF (NYSE:CPAI)

Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.